Dendritic cells and their involvement in atherosclerosis

Current Opinion in Lipidology

Volumn 11, Issue 5, 2000, Pages 511-517

  Bobryshev, Yuri V ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA; ARTERY WALL; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL AGGREGATION; CELL MIGRATION; CELLULAR DISTRIBUTION; DENDRITIC CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ARTERIES; ARTERIOSCLEROSIS; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOTHERAPY;

EID: 0033781944     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200010000-00009     Document Type: Review

References (71)

1. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantification, tissue distribution
2. Detection of activated T lymphocytes in the human atherosclerotic plaque
3. Atherosclerosis-an inflammatory disease
4. Immunomodulation of atherosclerosis: Myth and reality
5. Ultrastructural recognition of cells with dendritic cell morphology in human aortic intima. Contacting interactions of Vascular Dendritic Cells in athero-resistant and athero-prone areas of the normal aorta
6. Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions
7. Dendritic cells and control of immunity
8. Dendritic cells
9. Origin, maturation and antigen presenting function of dendritic cells
10. Developmental regulation of dendritic cell function
11. Dendritic cells: A link between innate and adaptive immunity
12. Cutting edge: Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function
13. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
14. Natural adjuvants: Endogenous activators of dendritic cells
15. How MHC class II molecules acquire peptide cargo: Biosynthesis and trafficking through the endocytic pathway
16. The CD1 family: A third lineage of antigen-presenting molecules
17. Capture and processing of exogenous antigens for presentation on MHC molecules
18. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells
19. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells
20. Accessory molecules for MHC class II peptide loading
21. Transport of peptide-MHC class II complexes in developing dendritic cells
22. Selective transport of intrernalized antigens to the cytosol for MHC class I presentation in dendritic cells
23. Abundant empty class II MHC molecules on the surface of immature dendritic cells
24. Naked antigen-presenting molecules on dendritic cells
25. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses
26. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking
27. Human epidermal Langerhans cells cointernalize by receptor-mediated endocytosis 'nonclassical' major histocompatibility complex class I molecules (T6 antigens) and class II molecules (HLA-DR antigens)
28. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytotic receptor that induces the formation of Birbeck granules
29. Cloning of a second dendritic-cell-associated C-type lectin (Dectin-2) and its alternatively spliced isoforms
30. The role of dendritic cells in the induction and regulation of immunity to microbial infection
31. Role of dendritic and follicular dendritic cells in HIV infection and pathogenesis
32. Langerhans cells and chemical allergy
33. Dendritic cell vaccines for cancer immunotherapy
34. Langerhans cells of human arterial intima: Uniform by stellate appearance but different by nature
35. Vascular dendritic cells and atherosclerosis
36. Structural heterogeneity and contacting interactions of vascular dendritic cells in early atherosclerotic lesions of the human aorta
37. Structural peculiarities of vascular dendritic cell tubulovesicular system in human atherosclerotic aorta
38. Formation of Birbeck granule-like structures in vascular dendritic cells in human atherosclerotic aorta. Lagantibody to epidermal Langerhans cells recognizes cells in the aortic wall
39. 55-kD actin-bundling protein (p 55) is a specific marker for identifying vascular dendritic cells
40. The cell adhesion molecule E-cadherin is widely expressed in human atherosclerotic lesions
41. S-100 positive cells in human arterial intima and in atherosclerotic lesions
42. A previously unrecognized site of local accumulation of mononuclear cells: The vascular-associated lymphoid tissue
43. Atherosclerosis, autoimmunity and vascular-associated lymphoid tissue (VALT)
44. Clustering of dendritic cells in athero-prone areas of the aorta
45. Neovascular expression of VE-cadherin in human atherosclerotic arteries and its relation to intimal inflammation
46. Subset of vascular dendritic cells transforming into foam cells in human atherosclerotic lesions
47. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
48. Mechanisms of lipid antigen presentation by CD1
49. Self glycolipids as T-cell autoantigens
50. CD1 expression in human atherosclerosis. A potential mechanism for T cell activation by foam cells
51. Ultrastructural evidence for association of vascular dendritic cells with T-lymphocytes and with B-cells in human atherosclerosis
52. Immunophenotypic analysis of the aortic aneurysm wall suggests that vascular dendritic cells are involved in immune responses
53. Immunophenotypic analysis of the aortic wall in Takayasu's arteritis: Involvement of lymphocytes, dendritic cells and granulocytes in immuno-inflammatory reactions
54. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomical sites
55. Apoptosis: Basic mechanisms and implications for cardiovascular disease
56. Cell death in human atherosclerotic plaques involves both oncosis and apoptosis
57. Cell death in atheromatous plaque of the carotid artery occurs through necrosis rather than apoptosis
58. Cutting edge: Receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells
59. Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake
60. Immunohistochemical localization of heat shock protein-70 in normal-appearing and atherosclerotic specimens of human arteries
61. Expression of secretory group II phospholipase A2 by CD1a positive cells in human atherosclerotic plaques
62. S100 protein is expressed in induced atherosclerotic lesions of hypercholesterolaemic rats
63. Atherosclerotic lesions of apolipoprotein E deficient mice contain cells expressing S100
64. Ultrastructural identification of cells with dendritic cell appearance in atherosclerotic aorta of apolipoprotein E deficient mice
65. Expression of relB is required for the development of thymic medulla and dendritic cells
66. Induction of tolerance by IL-10-treated dendritic cells
67. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity
68. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases
69. Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination
70. Gene-modified dendritic cells for use in tumor vaccines